Clinical Development of T-Cell Bispecific Antibodies: Review, Challenges, and Prospective Solutions in Solid Tumor
Chika Ogami, Takahiro Ishiguro
us (code pays fourni par la source)
0 citations
Methods in molecular biology
Takahiro Ishiguro
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
92Publications signalées
1548Citations signalées
1Affiliations récentes
Les institutions déclarées
Les domaines associés
Monoclonal and Polyclonal Antibodies ResearchMetallurgy and Material FormingCAR-T cell therapy researchGlycosylation and Glycoproteins ResearchMetal Forming Simulation Techniques
Les publications récentes
Kori-tofu ameliorates obesity and steatotic liver disease through enhancing GLP-1 production in the ileum
Pan Diao, Xuguang Zhang, Takahiro Ishiguro, Xiaojing Wang et autres
cn, jp, sk (code pays fourni par la source)
0 citations
International Journal of Biological Macromolecules
Molecular subtypes of hepatocellular carcinoma linked to liver cell lineages and clinical outcomes of combination immunotherapy
Yulei Wang, Yinghui Guan, Alexander R. Abbas, Yuji Sano et autres
us, ch, de (code pays fourni par la source)
8 citations
Cell Reports Medicine
Inhibitory Effect of Kori-tofu Protein on Denervation-Induced Atrogene Expression in Mouse Skeletal Muscle
Takayuki Uchida, Madoka Kohno, Chinami Ito, Erika Yamano et autres
jp (code pays fourni par la source)
0 citations
Biological Sciences in Space
Effect of 4-Week Consumption of Soy Kori-tofu on Cardiometabolic Health Markers: A Double-Blind Randomized Controlled Cross-Over Trial in Adults with Mildly Elevated Cholesterol Levels
Maartje van den Belt, Sandra van der Haar, Els Oosterink, Tom van Loenhout et autres
nl (code pays fourni par la source)
3 citations
Nutrients
Combination of T cell-redirecting bispecific antibody ERY974 and chemotherapy reciprocally enhances efficacy against non-inflamed tumours
Yuji Sano, Yumiko Azuma, Toshiaki Tsunenari, Yoko Kayukawa et autres
us (code pays fourni par la source)
22 citations
Nature Communications
Determination of starting dose of the T cell-redirecting bispecific antibody ERY974 targeting glypican-3 in first-in-human clinical trial
Shunichiro Komatsu, Yoko Kayukawa, Yoko Miyazaki, Akihisa Kaneko et autres
us (code pays fourni par la source)
12 citations
Scientific Reports
A Soybean Resistant Protein-Containing Diet Increased the Production of Reg3γ Through the Regulation of the Gut Microbiota and Enhanced the Intestinal Barrier Function in Mice
Tasuku Ogita, Fu Namai, Ayane Mikami, Takahiro Ishiguro et autres
jp (code pays fourni par la source)
11 citations
Frontiers in Nutrition
Abstract CT111: Results of a phase 1 dose escalation study of ERY974, an anti-glypican 3 (GPC3)/CD3 bispecific antibody, in patients with advanced solid tumors
Howard Safran, Mihaela Druta, Michael A. Morse, Filipa Lynce et autres
us (code pays fourni par la source)
14 citations
Cancer Research
Exploitation of Elevated Extracellular ATP to Specifically Direct Antibody to Tumor Microenvironment
Futa Mimoto, K. Tatsumi, Shun Shimizu, Shojiro Kadono et autres
us, jp (code pays fourni par la source)
68 citations
Cell Reports
Preclinical PET imaging of bispecific antibody ERY974 targeting CD3 and glypican 3 reveals that tumor uptake correlates to T cell infiltrate
Stijn J.H. Waaijer, Danique Giesen, Takahiro Ishiguro, Yuji Sano et autres
nl (code pays fourni par la source)
27 citations
Journal for ImmunoTherapy of Cancer
Property changes of frozen soybean curd during frozen storage in “Kori-tofu” manufacturing process
Rika Kobayashi, Takahiro Ishiguro, Ami Ozeki, Kiyoshi Kawai et autres
jp (code pays fourni par la source)
28 citations
Food Hydrocolloids
BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.